FACULTY


MELANOMA BRIDGE 2015
December 1-4, 2015



Sanjiv Agarwala
St. Luke's University Hospital and Temple University, Bethlehem, Pennsylvania

Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy

Carlo Bifulco
Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, Oregon

Gerardo Botti
National Cancer Institute “Fondazione G. Pascale” of Naples, Italy

Jorge Camarero
Oncology Area, Spanish Agency for Medicines and Medical Devices, AEMPS, Spain
Oncology assessor at the European Medicines Agency, EMA

Alessandra Cesano
NanoString Technologies, Seattle, Washington

Pier Luigi Canonico
Department of Scienze del Farmaco, University of Piemonte Orientale, Novara, Italy

Gennaro Ciliberto
National Cancer Institute “Fondazione G. Pascale” of Naples, Italy

Michael Davies
Department of Melanoma Medical Oncology, Department of Systems Biology, University of Texas MD Anderson Cancer Center, Texas

Francesco De Lorenzo
Italian Federation of Volunteer-based Cancer Organizations, FAVO

Sandra Demaria
New York University School of Medicine and NYU Langone Medical Center Alexandria Center for Life Sciences, New York

Reinhard Dummer
University of Zurich Hospital, Department of Dermatology, Zurich

Alexander Eggermont
Institut de Cancérologie Gustave Roussy, Villejuif, Paris-Sud, France

Soldano Ferrone
Massachusetts General Hospital, Boston, Massachusetts

Paolo Foggi*
Italian Medicines Agency, AIFA

Bernard A. Fox
Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, Oregon

Yang Xin Fu
Donnelley Biological Sciences Learning Center, University of Chicago, Illinois

Thomas F. Gajewski
Department of Pathology and Department of Medicine, Section of Hematology/Oncology, Chicago, Illinois

Jerome Galon
INSERM (National Institute of Health and Medical Research), Paris, France

Claus Garbe
Division of Dermatologic Oncology Department of Dermatology Eberhard Karls University Tuebingen, Germany

Valerie Guild
AIM at Melanoma, Richmond, California

Claudio Jommi
Department of Pharmaceutical Sciences, University of Piemonte Orientale, Novara, Italy

Howard Kaufman
Rutgers Cancer Institute of New Jersey, New Jersey

Samir Khleif
Georgia Regents University Cancer Center, Augusta, Georgia

John M. Kirkwood
Melanoma and Skin Cancer Program University of Pittsburgh Cancer Institute, Pennsylvania

Michael Krauthammer
Yale University School of Medicine, Department of Pathology, New Haven, Connecticut

Roger Lo
Melanoma Clinic in Dermatology Member, Jonsson Comprehensive Cancer Center David Geffen School of Medicine at UCLA, Los Angeles, California

Michele Maio
Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Italy

Francesco M. Marincola
Sidra Medical and Research Center, Doha, Qatar

Giuseppe Masucci
Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden

Deborah Morrison
National Institute for Health and Care Excellence, NICE

Nicola Mozzillo
Department Melanoma and Soft Tissues, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy

Franck Pages
Service d'Immunologie Biologique, Hôpital Européen Georges Pompidou, Paris, France

Giuseppe Palmieri
Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy

Francesco Perrone
Clinical Trials Unit, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy

Michael Postow
Memorial Sloan Kettering Cancer Center, New York

Igor Puzanov
Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee

Tilman Rau
Institute of Pathology, University of Bern, Switzerland

Licia Rivoltini
National Cancer Institute of Milan, Italy

Paola Queirolo
National Institute for Cancer Research, Genova, Italy

Stefani Spranger
Department of Patholog, University of Chicago, Illinois

David Frank Stroncek
Department of Transfusion Medicine, NIH Clinical Center, Bethesda, Maryland

Ahmad Tarhini
Melanoma and Skin Cancer Program University of Pittsburgh Cancer Institute, Pennsylvania

Janis M. Taube
Johns Hopkins University SOM, Baltimore, Maryland

Alessandro Testori
Dermato-oncology Surgery Division, European Institute of Oncology, Milan, Italy

Magdalena Thurin
Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland

Ena Wang
Sidra Medical and Research Centre, Doha, Qatar

Jennifer A. Wargo
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Cassian Yee
Solid Tumor Cell Therapy and ACT Platform, UT MD Anderson Cancer Center, Texas

Hassane Zarour
University of Pittsburgh Cancer Institute Hillman Cancer Center, Pennsylvania

Laurence Zitvogel
Institut Gustave Roussy, Villejuif, Paris-Sud, France


* To be confirmed



For information please contact info@melanomabridge.org